Time-resolved fluorescence imaging for quantitative histochemistry using lanthanide chelates in nanoparticles and conjugated to monoclonal antibodies
Tissue and cell examinations have a potential to produce extremely valuable information about antigen quantities in samples. Using currently available methods, a truly quantitative analysis is nearly impossible. We have previously shown that immunohistochemical (IHC) detection of prostate‐specific a...
Saved in:
Published in: | Luminescence (Chichester, England) Vol. 15; no. 6; pp. 389 - 397 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Chichester, UK
John Wiley & Sons, Ltd
01-11-2000
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Tissue and cell examinations have a potential to produce extremely valuable information about antigen quantities in samples. Using currently available methods, a truly quantitative analysis is nearly impossible. We have previously shown that immunohistochemical (IHC) detection of prostate‐specific antigen and human glandular kallikrein from prostatic tissue, together with time‐resolved fluorescence imaging (TRFI), is a suitable method for obtaining quantitative data from biological samples and that the signal response is linear. In this paper we show that Eu‐chelate containing particles in the nanometer range are suitable labels for quantitative IHC. Even single nanoparticle molecules can be detected by TRFI and the signals measured can be readily quantitated. The signal intensity correlates very well with the amount of bound label, and the use of nanoparticles could markedly improve the sensitivity of quantitative IHC methods. TRFI provides a powerful tool for providing quantitative data about antigens or transcripts in tissue sections or cultured cells. It is also of major importance in standardization and optimization of protocols for fixation and tissue preparation, including antigen retrieval methods. Copyright © 2000 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | Cancer Research Fund, Malmö Hospital, Sweden ArticleID:BIO626 Swedish Cancer Society Research Fund - No. 4292-B99-01XAB Foundation for Urology Research, Malmö, Sweden ark:/67375/WNG-R9T2P9GX-M istex:135198C84C30594C0215B9362BB6658E889DC70C Thulefjord Foundation ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1522-7235 1522-7243 |
DOI: | 10.1002/1522-7243(200011/12)15:6<389::AID-BIO626>3.0.CO;2-7 |